Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age.
Russell, FM;
Carapetis, JR;
Burton, RL;
Lin, J;
Licciardi, PV;
Balloch, A;
Tikoduadua, L;
Waqatakirewa, L;
Cheung, YB;
Tang, MLK;
+2 more...Nahm, MH;
Mulholland, EK;
(2011)
Opsonophagocytic activity following a reduced dose 7-valent pneumococcal conjugate vaccine infant primary series and 23-valent pneumococcal polysaccharide vaccine at 12 months of age.
Vaccine, 29 (3).
pp. 535-544.
ISSN 0264-410X
DOI: https://doi.org/10.1016/j.vaccine.2010.10.046
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
Opsonophagocytic activity (OPA) was measured following reduced infant doses of 7-valent pneumococcal conjugate vaccine (PCV-7) with or without 23-valent pneumococcal polysaccharide vaccine (PPV-23) at 12 months, and subsequent re-exposure to a small dose of pneumococcal polysaccharide antigens (mPPS) at 17 months. Fijian infants were randomized to receive 0, 1, 2, or 3 PCV-7 doses. Half received PPV-23 at 12 months and all received mPPS at 17 months. OPA was performed on up to 14 serotypes. Three and 2 PCV-7 doses resulted in similar OPA for most PCV-7 serotypes up to 9 months and for half of the serotypes at 12 months. A single dose improved OPA compared with the unvaccinated group. PPV-23 significantly improved OPA for all serotypes tested but in general, was associated with diminished responses following re-challenge.